Why PsyBio Will be the Leader in the Psychedelic
Drug Discovery Industry
01.
PsyBio has compiled an ever-expanding portfolio of over 80 molecules, utilizing scientific methodology to prioritize ongoing development
02.
PsyBio is an industry-first and leader in developing cheaper, faster, and greener
psychedelic inspired compound discovery and production
03.
PsyBio has contracted with three globally acclaimed and experienced contract
manufacturing organizations for process development and commercialization of lead
compounds
PsyBio is one of a small number of companies actively working towards US FDA sanctioned clinical trials in the psychedelic inspired biotherapeutic space
